Literature DB >> 8749672

The Streptococcus milleri group as a cause of pulmonary infections.

T Shinzato1, A Saito.   

Abstract

Streptococci that colonize the mouth and upper respiratory tract tend to be considered harmless commensals. In 45 cases of acute pneumonia and/or pulmonary abscess and 25 cases of thoracic empyema, the predominant species recovered were anaerobic bacteria and the Streptococcus milleri group, which encompasses the oral species Streptococcus anginosus, Streptococcus constellatus, and Streptococcus intermedius. The isolation of most S. milleri organisms along with oral anaerobes indicated synergy between these groups. Studies in a mouse model of pneumonia demonstrated this synergy; mortality was higher, histopathologic abnormalities were more marked (reflecting acute pneumonia followed by pulmonary abscess or empyema), and viable bacteria were more numerous in the lungs of mice with mixed infections caused by the S. milleri group and anaerobes than in the lungs of those with monomicrobial infection. In vitro studies elucidated a possible mechanism of this synergistic effect: anaerobes may enhance the growth of the S. milleri group and/or inhibit the bactericidal activity of the host. We conclude that the S. milleri group is more important in pulmonary infections than has previously been recognized.

Entities:  

Mesh:

Year:  1995        PMID: 8749672     DOI: 10.1093/clind/21.supplement_3.s238

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  29 in total

1.  BTS guidelines for the management of pleural infection.

Authors:  C W H Davies; F V Gleeson; R J O Davies
Journal:  Thorax       Date:  2003-05       Impact factor: 9.139

2.  Pyopneumothorax due to Streptococcus milleri.

Authors:  Philipp Eller; Igor Theurl; Florian Koppelstaetter; Guenter Weiss
Journal:  Wien Klin Wochenschr       Date:  2006-05       Impact factor: 1.704

3.  Streptococcus anginosus endocarditis and multiple liver abscesses in a splenectomised patient.

Authors:  Talya Finn; Ami Schattner; Ina Dubin; Regev Cohen
Journal:  BMJ Case Rep       Date:  2018-04-27

4.  Multiple lung abscesses secondary to a uterine empyema caused by an intrauterine device.

Authors:  M van Laren; N C van Walree; J A J W Kluytmans
Journal:  Infection       Date:  2011-04-22       Impact factor: 3.553

5.  Rapid developing empyema by group F beta Streptococcus anginosus group.

Authors:  Muhammad Azharuddin; Dy Prudence; Prem Shanker Shukla; Ajay Mathur
Journal:  BMJ Case Rep       Date:  2017-07-13

Review 6.  From focal sepsis to periodontal medicine: a century of exploring the role of the oral microbiome in systemic disease.

Authors:  Purnima S Kumar
Journal:  J Physiol       Date:  2016-08-28       Impact factor: 5.182

7.  Acute bronchopulmonary infection due to Streptococcus milleri in a child with cystic fibrosis.

Authors:  A Cade; M Denton; K G Brownlee; N Todd; S P Conway
Journal:  Arch Dis Child       Date:  1999-03       Impact factor: 3.791

8.  Macrolide and clindamycin resistance in Streptococcus milleri group isolates from the airways of cystic fibrosis patients.

Authors:  Margot E Grinwis; Christopher D Sibley; Michael D Parkins; Christina S Eshaghurshan; Harvey R Rabin; Michael G Surette
Journal:  Antimicrob Agents Chemother       Date:  2010-04-19       Impact factor: 5.191

9.  Characterization of Streptococcus milleri group isolates from expectorated sputum of adult patients with cystic fibrosis.

Authors:  Margot E Grinwis; Christopher D Sibley; Michael D Parkins; Christina S Eshaghurshan; Harvey R Rabin; Michael G Surette
Journal:  J Clin Microbiol       Date:  2009-12-09       Impact factor: 5.948

10.  A polymicrobial perspective of pulmonary infections exposes an enigmatic pathogen in cystic fibrosis patients.

Authors:  Christopher D Sibley; Michael D Parkins; Harvey R Rabin; Kangmin Duan; Jens C Norgaard; Michael G Surette
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-23       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.